Grantee Research Project Results
Publications Details for Grant Number R824762
Biologically-Based Dose-Response Models for Cancer Risk Assessment
Other Views
- All
Publications - Selected
Publication Types - Journal
Articles - Publications Submitted
After Final Report - Redisplay this page without
Reference Title, Journal, and Author Columns - Display this Page
in RIS Format
Reference Type | Reference Title | Journal | Author | Citation | Progress Report Year | Document Sources |
---|---|---|---|---|---|---|
Book Chapter | Two-mutation carcinogenesis model. | None | Moolgavkar SH | Moolgavkar SH. Two-mutation carcinogenesis model. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Hoboken, NJ: John Wiley & Sons, Ltd., 1998, pp. 4635-4639. |
R824762 (Final) |
not available |
Journal Article | A biologically-based model for the analysis of premalignant foci of arbitrary shape. | MATHEMATICAL BIOSCIENCES | Dewanji A, Luebeck EG, Moolgavkar SH | Dewanji A, Luebeck EG, Moolgavkar SH. A biologically-based model for the analysis of premalignant foci of arbitrary shape. Mathematical Biosciences 1996;135(1):55-68. |
R824762 (Final) |
|
Journal Article | Recent bioassay results on coal tars and benzo(a)pyrene: implications for risk assessment. | REGULATORY TOXICOLOGY AND PHARMACOLOGY | Gaylor DW, Moolgavkar SH, Krewski D, Goldstein LS | Gaylor DW, Moolgavkar SH, Krewski D, Goldstein LS. Recent bioassay results on coal tars and benzo(a)pyrene: implications for risk assessment. Regulatory Toxicology and Pharmacology 1998;28(2):178-179. |
R824762 (Final) |
|
Journal Article | Some properties of the hazard function of the two-mutation clonal expansion model. | RISK ANALYSIS | Heidenreich W, Luebeck KM, Moolgavkar SH | Heidenreich W, Luebeck KM, Moolgavkar SH. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Analysis 1997;17(3):391-399. |
R824762 (Final) |
|
Journal Article | Analysis of solid cancer incidence among atomic bomb survivors using a two-stage model of carcinogenesis. | RADIATION RESEARCH | Kai M, Luebeck KM, Moolgavkar SH | Kai M, Luebeck KM, Moolgavkar SH. Analysis of solid cancer incidence among atomic bomb survivors using a two-stage model of carcinogenesis. Radiation Research 1997;148(4):348-358. |
R824762 (Final) |
|
Journal Article | Biologically based cancer modelling. | DRUG AND CHEMICAL TOXICOLOGY | Luebeck KM, Moolgavkar SH | Luebeck KM, Moolgavkar SH. Biologically based cancer modelling. Drug and Chemical Toxicology 1996;19(3):221-243. |
R824762 (Final) |
|
Journal Article | Quantitative analysis of enzyme-altered foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachloro-p-dioxin. | TOXICOLOGY AND APPLIED PHARMACOLOGY | Moolgavkar SH, Luebeck EG, Buchmann A, Bock KW | Moolgavkar SH, Luebeck EG, Buchmann A, Bock KW. Quantitative analysis of enzyme-altered foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachloro-p-dioxin. Toxicology and Applied Pharmacology 1996;138(1):31-42. |
R824762 (Final) |
|
Journal Article | Stochastic cancer models: application to analyses of solid cancer incidence in the cohort of A-bomb survivors. | NUCLEAR ENERGY | Moolgavkar SH | Moolgavkar SH. Stochastic cancer models: application to analyses of solid cancer incidence in the cohort of A-bomb survivors. Nuclear Energy 1997;36(6):447-451. |
R824762 (Final) |
|
Journal Article | Comments on papers on U-shaped dose-response relationships for carcinogens. | HUMAN & EXPERIMENTAL TOXICOLOGY | Moolgavkar SH | Moolgavkar SH. Comments on papers on U-shaped dose-response relationships for carcinogens. Human and Experimental Toxicology 1998;17(12):708-710. |
R824762 (Final) |
|
The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.